NOVO — Juni 2025
-
Mandag
Novo Nordisk kan løbe med opmærksomheden mandag, efter at medicinalkæmpen søndag har holdt sin forsknings- og udviklingsdag i forbindelse med ADA-konferencen. -
Novo får sænket sit kursmål med 18 pct. hos amerikansk analysehus https://proinvestor.com/investornyt/1331362/novo-far-saenket-sit-kursmal-med-18-pct-hos-amerikansk-analysehus
-
Novos vægttabsmiddel blåstemples af hjertelæger i USA https://proinvestor.com/investornyt/1331486/novos-vaegttabsmiddel-blastemples-af-hjertelaeger-i-usa
-
Novo Nordisk: De første fulde fase 1 og 2-data for Amycretin https://proinvestor.com/boards/126885
-
Højdosis Wegovy gav over 21% vægttab - 1/3 25% og derover https://proinvestor.com/boards/126888
-
Novo Nordisk med 2 stærke datasæt https://proinvestor.com/boards/126893/
-
Muscle-preserving drugs could generate over $30 billion in sales by 2035, TD Cowen says - https://www.reuters.com/business/healthcare-pharmaceuticals/muscle-preserving-drugs-could-generate-over-30-billion-sales-by-2035-td-cowen-2025-06-20/ Reuters
-
-
Lilly's oral GLP-1, orforglipron - data fra fase 3 https://proinvestor.com/boards/126900
-
Ærgerligt at Novo afviser
https://ekstrabladet.dk/penge/fra-ozempic-til-ozem-pik-maend-jubler/10856045 -
Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine https://proinvestor.com/boards/126912
-
Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=916355#
-
CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine. https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=916353
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind